Expertise in
30
conditions

Dr. Nader Sanai

Neurosurgery
Neurosurgical Associates LTD.
2910 N 3rd Ave, 
Phoenix, AZ 
Expertise in
30
conditions
Neurosurgical Associates LTD.
2910 N 3rd Ave, 
Phoenix, AZ 

Overview

Nader Sanai is a Neurosurgery provider in Phoenix, Arizona. Dr. Sanai is highly rated in 30 conditions, according to our data. His top areas of expertise are Brain Tumor, Glioma, Glioblastoma, Awake Craniotomy, and Gastrostomy.

His clinical research consists of co-authoring 129 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Neurosurgery

Licenses

Neurological Surgery in AZ

Hospital Affiliations

St Josephs Hospital And Medical Center
Yavapai Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Neurosurgical Associates LTD.
2910 N 3rd Ave, Phoenix, AZ 85013
Other Locations
Office
7242 E Osborn Rd Ste 420, Scottsdale, AZ 85251

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 0 Study of Infigratinib in Recurrent High-Grade Glioma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration With PK Triggered Expansion Cohort
A Phase 0 Study of Infigratinib in Recurrent High-Grade Glioma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration With PK Triggered Expansion Cohort
Enrollment Status: Terminated
Publish Date: October 24, 2025
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Early Phase 1
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Radiation, Procedure, Drug
Study Drug: Temozolomide
Study Phase: Phase 3
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Rb-Intact Recurrent High-Grade Glioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Rb-Intact Recurrent High-Grade Glioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Drug
Study Drugs: Ribociclib, Everolimus
Study Phase: Early Phase 1
A Phase 0/II Study of Ribociclib (LEE011) in Preoperative Rb-Positive Recurrent High-Grade Glioma and Meningioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
A Phase 0/II Study of Ribociclib (LEE011) in Preoperative Rb-Positive Recurrent High-Grade Glioma and Meningioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
Enrollment Status: Active_not_recruiting
Publish Date: March 14, 2025
Intervention Type: Drug
Study Drug: Ribociclib
Study Phase: Early Phase 1
A Phase 0/2 Study of LY3214996 (ERK Inhibitor) in Combination With Abemaciclib (CDK4 and 6 Inhibitor) in Recurrent Glioblastoma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
A Phase 0/2 Study of LY3214996 (ERK Inhibitor) in Combination With Abemaciclib (CDK4 and 6 Inhibitor) in Recurrent Glioblastoma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
Enrollment Status: Active_not_recruiting
Publish Date: February 28, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, LY3214996
Study Phase: Early Phase 1
A Phase 0/2 Clinical Trial of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma Patients
A Phase 0/2 Clinical Trial of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: February 28, 2025
Intervention Type: Drug, Radiation
Study Drugs: Pamiparib, Olaparib, Temozolomide
Study Phase: Early Phase 1
A Phase 0 'Trigger' Trial of Niraparib in Newly-diagnosed Glioblastoma and Recurrent IDH1/2(+) ATRX Mutant Glioma
A Phase 0 'Trigger' Trial of Niraparib in Newly-diagnosed Glioblastoma and Recurrent IDH1/2(+) ATRX Mutant Glioma
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2025
Intervention Type: Radiation, Drug
Study Drug: Niraparib
Study Phase: Early Phase 1
A Phase 2 Dose-escalation Study Examining the Safety, Pharmacokinetics, and Preliminary Efficacy of Ascending Drug and Energy Dose Combinations for Sonodynamic Therapy Using SONALA-001 in Combination with Exablate 4000 Type 2.0 MR-Guided Focused Ultrasound in Subjects with Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma (DMG)
A Phase 2 Dose-escalation Study Examining the Safety, Pharmacokinetics, and Preliminary Efficacy of Ascending Drug and Energy Dose Combinations for Sonodynamic Therapy Using SONALA-001 in Combination with Exablate 4000 Type 2.0 MR-Guided Focused Ultrasound in Subjects with Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma (DMG)
Enrollment Status: Suspended
Publish Date: September 19, 2024
Intervention Type: Combination product
Study Drug: SONALA-001+MR-Guided Focused Ultrasound device
Study Phase: Phase 2
Barrow 5-ALA Intraoperative Confocal Evaluation Trial
Barrow 5-ALA Intraoperative Confocal Evaluation Trial
Enrollment Status: Completed
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: 5-Aminolevulinic acid
Study Phase: Phase 3
A Phase 0/II Study of Ceritinib (LDK378) in Preoperative Glioblastoma Multiforme (GBM) and CNS Metastasis Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
A Phase 0/II Study of Ceritinib (LDK378) in Preoperative Glioblastoma Multiforme (GBM) and CNS Metastasis Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration
Enrollment Status: Completed
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Early Phase 1
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 10 Less Clinical Trials

129 Total Publications

An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma.
An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma.
Journal: Science translational medicine
Published: November 26, 2025
Similar Doctors
Michael T. Lawton
Expertise in
47
conditions
Dr. Michael T. Lawton
Neurosurgery | Neurology
Expertise in
47
conditions
Dr. Michael T. Lawton
Neurosurgery | Neurology

Barrow Brain And Spine

2910 N 3rd Ave, 
Phoenix, AZ 
 (0.1 miles away)
602-406-3181
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Lawton is a Neurologist and a Neurosurgery provider in Phoenix, Arizona. Dr. Lawton is highly rated in 47 conditions, according to our data. His top areas of expertise are Arteriovenous Malformation, Cerebral Arteriovenous Malformation, Brain Aneurysm, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery. Dr. Lawton is currently accepting new patients.

Andrew F. Ducruet
Expertise in
27
conditions
Dr. Andrew F. Ducruet
Neurosurgery
Expertise in
27
conditions
Dr. Andrew F. Ducruet
Neurosurgery

Barrow Brain And Spine

2910 N 3rd Ave, 
Phoenix, AZ 
 (0.1 miles away)
602-406-3181
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Ducruet is a Neurosurgery provider in Phoenix, Arizona. Dr. Ducruet is highly rated in 27 conditions, according to our data. His top areas of expertise are Subarachnoid Hemorrhage, Brain Aneurysm, Stroke, Thrombectomy, and Endovascular Embolization. Dr. Ducruet is currently accepting new patients.

Expertise in
27
conditions
Dr. Felipe Albuquerque
Neurosurgery
Expertise in
27
conditions
Dr. Felipe Albuquerque
Neurosurgery

Neurosurgical Associates LTD.

2910 N 3rd Ave, 
Phoenix, AZ 
 (0.1 miles away)
602-406-3469
Languages Spoken:
English
See accepted insurances

Felipe Albuquerque is a Neurosurgery provider in Phoenix, Arizona. Dr. Albuquerque is highly rated in 27 conditions, according to our data. His top areas of expertise are Brain Aneurysm, Subarachnoid Hemorrhage, Arteriovenous Malformation, Stent Placement, and Endovascular Embolization.

Frequently Asked Questions about Dr. Nader Sanai

How do I make an appointment with Dr. Nader Sanai?

You can book an appointment with Dr. Nader Sanai by calling their office at 602-406-3181. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nader Sanai a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nader Sanai is classified as an Elite expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nader Sanai specialize in?

While Dr. Nader Sanai is a Neurosurgery, they have specific expertise in Brain Tumor, Glioma, and Glioblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Nader Sanai participate in research or clinical trials?

Yes. Dr. Nader Sanai has published 129 articles and abstracts on conditions like Brain Tumor. You can view a list of Dr. Nader Sanai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nader Sanai accept my insurance?

Dr. Nader Sanai accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 602-406-3181 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sanai's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 16 Distinguished Conditions
View All 7 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile